BEYONTTRA

Class [005]
Pharmaceuticals for use in the treatment of oncological diseases and disorders, cardiological diseases and disorders, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases, neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, and cerebral palsy, genetic diseases and disorders, orthopedic diseases and disorders, namely, arthritis, osteoporosis, fibromyalgia, and metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity, hyperlipidemia, insulin resistance, metabolic syndrome.